Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus (Q41268850)

28 September 2017

title

Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus (English)

1 reference

28 September 2017

0 references

Banerjee S

1

1 reference

28 September 2017

Livanos E

series ordinal

2

1 reference

28 September 2017

Vos JM

series ordinal

3

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

28 September 2017

1 reference

28 September 2017

volume

1

1 reference

28 September 2017

issue

12

1 reference

28 September 2017

page(s)

1303-1308

1 reference

Hematopoietic stem cell gene replacement therapy

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

Cloning of cDNAs for Fanconi's anaemia by functional complementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

Repair analysis of mitomycin C-induced DNA crosslinking in ribosomal RNA genes in lymphoblastoid cells from Fanconi's anemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

Gene transfer into hematopoietic progenitor and stem cells: progress and problems.

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

Lymphocyte gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

The ADA human gene therapy clinical protocol

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

A novel form of Epstein-Barr virus latency in normal B cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

Human artificial episomal chromosomes for cloning large DNA fragments in human cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

Molecular and cellular biology of Fanconi anemia

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

Chromatin domains as potential units of eukaryotic gene function

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

X-linked agammaglobulinemia and other immunoglobulin deficiencies

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

Immortalization of human primary B lymphocytes in vitro with DNA

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

New Epstein–Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNM1295-1303

7 January 2021

Identifiers

DOI

10.1038/NM1295-1303

1 reference

Dimensions Publication ID

28 September 2017

1029569396

0 references

1 reference